Trial intelligence / Profile preview

Transtympanic steroids versus gentamicin for unilateral Meniere's disease

2008-004803-78Phase 2Completed

Sponsor
Imperial College London
Start
Apr 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Meniere Disease comparing Transtympanic methylprednisolone with Transtympanic gentamicin (2 arms). Primary endpoint: Relief from vertigo attacks. Started Apr 2009; status: completed.

02

Drugs

methylprednisolonegentamicin
03

Conditions

Meniere Disease

Beyond the preview

Go deeper on 2008-004803-78.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-004803-78.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call